Product NDC: | 0187-0938 |
Proprietary Name: | Tasmar |
Non Proprietary Name: | Tolcapone |
Active Ingredient(s): | 100 mg/1 & nbsp; Tolcapone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0187-0938 |
Labeler Name: | Valeant Pharmaceuticals North America LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020697 |
Marketing Category: | NDA |
Start Marketing Date: | 20040727 |
Package NDC: | 0187-0938-07 |
Package Description: | 21 TABLET, FILM COATED in 1 BOTTLE (0187-0938-07) |
NDC Code | 0187-0938-07 |
Proprietary Name | Tasmar |
Package Description | 21 TABLET, FILM COATED in 1 BOTTLE (0187-0938-07) |
Product NDC | 0187-0938 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tolcapone |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20040727 |
Marketing Category Name | NDA |
Labeler Name | Valeant Pharmaceuticals North America LLC |
Substance Name | TOLCAPONE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |